Cargando…
Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts
IMPORTANCE: Most prisons and jails in the US discontinue medications for opioid use disorder (MOUD) upon incarceration and do not initiate MOUD prior to release. OBJECTIVE: To model the association of MOUD access during incarceration and at release with population-level overdose mortality and OUD-re...
Autores principales: | Chatterjee, Avik, Weitz, Michelle, Savinkina, Alexandra, Macmadu, Alexandria, Madushani, R. W. M. A., Potee, Ruth A., Ryan, Danielle, Murphy, Sean M., Walley, Alexander Y., Linas, Benjamin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105308/ https://www.ncbi.nlm.nih.gov/pubmed/37058306 http://dx.doi.org/10.1001/jamanetworkopen.2023.7036 |
Ejemplares similares
-
Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
por: Flam-Ross, Juliet M., et al.
Publicado: (2023) -
COVID-19 and treating incarcerated populations for opioid use disorder
por: Donelan, Christopher J., et al.
Publicado: (2021) -
The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York City()
por: Morgan, Jake R., et al.
Publicado: (2022) -
Projected Estimates of Opioid Mortality After Community-Level Interventions
por: Linas, Benjamin P., et al.
Publicado: (2021) -
2494. Massachusetts HCV Treatment Report Card: Hepatitis C Virus Care Cascade for Women of Reproductive Age with Opioid Use Disorder, 2014-2020
por: Epstein, Rachel L, et al.
Publicado: (2023)